BLEPHAMIDE is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Sulfacetamide Sodium; Prednisolone Acetate.
Product ID | 11980-022_01643437-7cdb-4f32-bb3e-8be326b99127 |
NDC | 11980-022 |
Product Type | Human Prescription Drug |
Proprietary Name | BLEPHAMIDE |
Generic Name | Sulfacetamide Sodium And Prednisolone Acetate |
Dosage Form | Suspension/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 1961-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA012813 |
Labeler Name | Allergan, Inc. |
Substance Name | SULFACETAMIDE SODIUM; PREDNISOLONE ACETATE |
Active Ingredient Strength | 100 mg/mL; mg/mL |
Pharm Classes | Sulfonamide Antibacterial [EPC],Sulfonamides [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1961-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA012813 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1961-10-01 |
Marketing Category | NDA |
Application Number | NDA012813 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1961-10-01 |
Marketing Category | NDA |
Application Number | NDA012813 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-10-29 |
Marketing End Date | 2012-01-18 |
Ingredient | Strength |
---|---|
SULFACETAMIDE SODIUM | 100 mg/mL |
SPL SET ID: | 0e5644af-2a3c-493a-bc24-174e5f36235b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0023-0313 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate |
11980-022 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BLEPHAMIDE 72119340 0724725 Live/Registered |
Allergan Pharmaceuticals, Inc. 1961-05-05 |